C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2011
11/29/2011	US8067161 Dopaminergic neuron proliferative progenitor cell marker Nato3
11/29/2011	US8067160 Genetic markers of schizophrenia
11/29/2011	US8067158 Methods and compositions for the diagnosis and treatment of schizophrenia
11/29/2011	US8067157 Expression cloning in filamentous fungi
11/29/2011	US8067156 From adeno-associated virus; for treatment of acute conditions requiring rapid gene expression
11/29/2011	US8067155 Receptor tyrosine kinase assays
11/29/2011	US8067154 Method and device for rapid detection of microorganisms by changing the shape of micro-colonies in micro-channels
11/29/2011	US8067153 Genes and polypeptides relating to prostate cancers
11/29/2011	US8067152 Liver cancer biomarkers
11/29/2011	US8067007 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
11/29/2011	US8067004 Surface antigen
11/29/2011	US8066991 Enzyme inhibitors of PAI-1
11/29/2011	US8066972 Altering memory by affecting staufen function
11/29/2011	CA2662024C Thermostablization of dna polymerase by protein folding pathway from a hyperthermophile archaeon, pyrococcus furiosus
11/29/2011	CA2628708C Method of quantifying membrane protein by using mass spectrometer
11/29/2011	CA2525657C Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats o6 of pseudomonas aeruginosa
11/29/2011	CA2499084C Actn3 genotype screen for athletic performance
11/29/2011	CA2440461C Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
11/29/2011	CA2414331C Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/29/2011	CA2378615C Modified cytochrome p450 monooxygenases
11/29/2011	CA2377567C High throughput assay system
11/29/2011	CA2315776C High throughput assay system
11/29/2011	CA2293632C Artificial antibody polypeptides
11/29/2011	CA2200202C Production of hydroxylated fatty acids in genetically modified plants
11/24/2011	WO2011146945A2 Alk and ros kinase in cancer
11/24/2011	WO2011146937A1 Methods and kits useful in diagnosing nsclc
11/24/2011	WO2011146825A2 Avian influenza h5n1 specific aptamers and their use
11/24/2011	WO2011146756A1 Methods and kits useful in the differentiation of burkholderia species
11/24/2011	WO2011146683A1 Methods and reagents for metabolomics and histology in a biological sample and a kit for the same
11/24/2011	WO2011146636A2 Reagents and methods for sirtuin capture
11/24/2011	WO2011146632A1 Methods for non-invasive prenatal ploidy calling
11/24/2011	WO2011146629A2 Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
11/24/2011	WO2011146531A1 Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (rtca) cardio instruments
11/24/2011	WO2011146458A1 Method of administration and treatment
11/24/2011	WO2011146422A1 Systems and methods for feature detection in mass spectrometry using singular spectrum analysis
11/24/2011	WO2011146411A1 Grp78 gene polymorphism rs391957 is associated with tumor recurrence and survival in gastrointestinal cancer patients
11/24/2011	WO2011146406A1 Germline polymorphisms in vegf predict clinical outcomes in cancer patients treated with sorafenib
11/24/2011	WO2011146405A1 Egf +61g/a and ts 5'utr 2r/3r polymorphisms predict clinical outcomes in cancer patients undergoing anti-egfr therapy
11/24/2011	WO2011146056A1 Tethered conformation capture
11/24/2011	WO2011145772A1 Method for detecting cancer events-regulating gene in ionizing radiation-irradiated mice, and gene group
11/24/2011	WO2011145764A1 Microorganism for quantifying homocysteine, and use thereof
11/24/2011	WO2011145725A1 Method and kit for diagnosing aim-related illness
11/24/2011	WO2011145722A1 Method of screening for compounds that control aim function
11/24/2011	WO2011145622A1 Method for detecting gastric cancer
11/24/2011	WO2011145614A1 Method for designing probe for detecting nucleic acid reference material, probe for detecting nucleic acid reference material, and nucleic acid detection system having probe for detecting nucleic acid reference material
11/24/2011	WO2011145126A2 A method for the preparation of conjugates based on transglutaminase
11/24/2011	WO2011145125A1 Chimeric biomarker for the early diagnosis and immunotherapy of cancer
11/24/2011	WO2011144951A1 Mycobacterial antigen composition
11/24/2011	WO2011144818A1 Method for detection of predisposition to atherosclerosis, coronary heart disease and related conditions
11/24/2011	WO2011144761A1 Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders
11/24/2011	WO2011144738A1 Critical gene targets for cytotoxic therapy
11/24/2011	WO2011144718A2 Methods and kits for diagnosing colorectal cancer
11/24/2011	WO2011144345A1 Reaction vessel for pcr device and method of performing pcr
11/24/2011	WO2011144304A1 Universally applicable lysis buffer and processing methods for the lysis of bodily samples
11/24/2011	WO2011144216A1 Method and kit for identifying compounds capable of inhibiting human papilloma virus replication
11/24/2011	WO2011143791A1 Microarray reader based on evanescent wave detection
11/24/2011	WO2011117259A9 Methods for identifying inhibitors of the type iii secretion system
11/24/2011	WO2011113813A3 Assay for analytes based on aggregation
11/24/2011	WO2011091106A3 Compositions and methods for gene signature - based chemical screening
11/24/2011	WO2011085258A3 Fluidics interface system
11/24/2011	WO2011082422A3 Human immunodeficiency virus (hiv-1) highly conserved and low variant sequences as targets for vaccine and diagnostic applications
11/24/2011	WO2011063198A3 Methods and compositions for modulating the activity of the interleukin-35 receptor complex
11/24/2011	WO2011050000A3 Single molecule nucleic acid nanoparticles
11/24/2011	WO2010142461A3 Treatment of coagulopathy with hyperfibrinolysis
11/24/2011	WO2010131114A3 Carbohydrate binding module and use thereof
11/24/2011	US20110289623 Compositions and methods for the modification of gene expression
11/24/2011	US20110289622 Expression cassettes for transgenic expression of nucleic acids
11/24/2011	US20110289620 Aad-1 event das-40278-9, related transgenic corn lines, event-specific identification thereof, and methods of weed control involving aad-1
11/24/2011	US20110289611 Rna sequence-specific mediators of rna interference
11/24/2011	US20110289609 Neurotransmitter Sensors and Methods of Using the Same
11/24/2011	US20110289608 Antisense modulation of interleukins 17 and 23 signaling
11/24/2011	US20110289607 Method of inhibiting gene expression
11/24/2011	US20110289606 Equine disease model for herpesvirus neurologic disease and uses thereof
11/24/2011	US20110289605 Animal Model for Osteoarthritis and Intervertebral Disc Disease
11/24/2011	US20110289604 Methods for Identifying Modulating Compounds of Lymphangiogenesis, Means Therefore, Compounds and Uses Thereof
11/24/2011	US20110289022 Methods for Plant Fiber Characterization and Identification
11/24/2011	US20110288158 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288153 Translation factors as anti-aging drug targets
11/24/2011	US20110288151 Methods of characterizing breast cancer and identifying treatments for same
11/24/2011	US20110288150 Oligonucleotides for Suppressing Cancer Cell Invasion and Migration
11/24/2011	US20110288149 Method of protecting against heart failure
11/24/2011	US20110288083 Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase
11/24/2011	US20110288082 Methods and compositions for inhibition of the transitional endoplasmic reticulum atpase
11/24/2011	US20110288034 Methods of identifying adipocyte specific genes, the genes identified, and their uses
11/24/2011	US20110288031 Identification of a novel bhd gene
11/24/2011	US20110288027 Targets, methods, and reagents for diagnosis and treatment of schizophrenia
11/24/2011	US20110288020 Use of VEGF and homologues to treat neuron disorders
11/24/2011	US20110288013 Glycemic control for reduction of cardiovascular disease risk in diabetic patients expressing haptoglobin 2-2
11/24/2011	US20110288008 Antibacterial and plasmid elimination agents
11/24/2011	US20110287982 Cell culture device
11/24/2011	US20110287972 Methods and Systems for Inferring Traits to Breed and Manage Non-Beef Livestock
11/24/2011	US20110287971 Multi-chain eukaryotic display vectors and uses thereof
11/24/2011	US20110287970 Microrna fingerprints during human megakaryocytopoiesis
11/24/2011	US20110287968 Methylation Assay
11/24/2011	US20110287967 Lung Cancer Methylation Markers
11/24/2011	US20110287966 Molecular markers for rice brown planthopper resistance gene
11/24/2011	US20110287964 Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans
11/24/2011	US20110287963 system useful for reporting protein-protein interactions in the bacterial periplasm
11/24/2011	US20110287958 Method for Using Gene Expression to Determine Colorectal Tumor Stage

1 ... 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 ... 3003